Today Cutera, Inc. (CUTR) Stock Rises

February 15, 2018 - By Linda Rogers

Investors sentiment decreased to 1.13 in 2017 Q3. Its down 1.09, from 2.22 in 2017Q2. It dived, as 10 investors sold Cutera, Inc. shares while 43 reduced holdings. 30 funds opened positions while 30 raised stakes. 11.40 million shares or 1.35% less from 11.56 million shares in 2017Q2 were reported.
Glenmede Na reported 0% stake. Voya Mgmt Ltd has invested 0% in Cutera, Inc. (NASDAQ:CUTR). Blackrock, a New York-based fund reported 1.51 million shares. Dalton Greiner Hartman Maher And has 76,340 shares for 0.18% of their portfolio. Retail Bank Of America Corp De stated it has 113,972 shares or 0% of all its holdings. Royal Bank & Trust Of Canada has 0% invested in Cutera, Inc. (NASDAQ:CUTR). Partner Inv Mgmt Limited Partnership reported 4,349 shares or 0.17% of all its holdings. Goldman Sachs Inc owns 0% invested in Cutera, Inc. (NASDAQ:CUTR) for 32,120 shares. Moreover, Tower Cap Ltd (Trc) has 0% invested in Cutera, Inc. (NASDAQ:CUTR) for 1,157 shares. Schwab Charles Invest Management reported 32,648 shares or 0% of all its holdings. Bogle Invest Mngmt Lp De has invested 0.29% in Cutera, Inc. (NASDAQ:CUTR). Invesco Limited accumulated 93,584 shares. Ameriprise Inc holds 127,600 shares or 0% of its portfolio. Icon Advisers holds 0.15% in Cutera, Inc. (NASDAQ:CUTR) or 52,310 shares. Edge Wealth Limited Liability Company holds 0% or 200 shares in its portfolio.

Since August 15, 2017, it had 0 buys, and 11 sales for $1.87 million activity. The insider SANTILLI RONALD J sold $969,976. Shares for $325,386 were sold by Reinstein James A.. 1,000 Cutera, Inc. (NASDAQ:CUTR) shares with value of $47,400 were sold by APFELBERG DAVID B. Pardos Miguel sold $467,000 worth of stock. On Tuesday, January 2 the insider Laber Larry sold $264,980.

The stock of Cutera, Inc. (NASDAQ:CUTR) is a huge mover today! The stock increased 8.15% or $3.8 during the last trading session, reaching $50.45. About 327,266 shares traded or 21.62% up from the average. Cutera, Inc. (NASDAQ:CUTR) has risen 102.00% since February 15, 2017 and is uptrending. It has outperformed by 85.30% the S&P500.
The move comes after 7 months positive chart setup for the $698.99 million company. It was reported on Feb, 15 by We have $51.96 PT which if reached, will make NASDAQ:CUTR worth $20.97M more.

Cutera, Inc. (NASDAQ:CUTR) Ratings Coverage

Among 3 analysts covering Cutera (NASDAQ:CUTR), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cutera had 8 analyst reports since January 4, 2017 according to SRatingsIntel. As per Tuesday, September 12, the company rating was maintained by Roth Capital. The firm has “Buy” rating by Maxim Group given on Thursday, July 13. The stock of Cutera, Inc. (NASDAQ:CUTR) earned “Buy” rating by Gabelli on Tuesday, June 27. On Tuesday, August 8 the stock rating was maintained by Roth Capital with “Buy”. Maxim Group maintained it with “Buy” rating and $3300 target in Tuesday, August 8 report. The rating was maintained by Maxim Group on Wednesday, January 4 with “Buy”. The firm has “Buy” rating given on Wednesday, August 9 by Gabelli.

More news for Cutera, Inc. (NASDAQ:CUTR) were recently published by:, which released: “Cutera Reports Fourth Quarter and Full Year 2017 Record Revenue and Financial …” on February 14, 2018.‘s article titled: “Cutera Showcases Expanded Portfolio at AAD” and published on February 15, 2018 is yet another important article.

Cutera, Inc., a medical device company, designs, develops, makes, markets, and services laser and other energy based aesthetics systems worldwide. The company has market cap of $698.99 million. The firm offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It has a 67.09 P/E ratio. It also provides excel V, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: